Top Markets
Coin of the day
Medeon Biodesign, Inc. Medeon Biodesign, Inc.

Medeon Biodesign, Inc.

6499
Rangering i aksjer #17676
Medeon Biodesign, Inc. engages in the research and development, manufacturing,... Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
Aksjekurs
$2.38
Markedsverdi
$231.21M
Endring (1 dag)
0.94%
Endring (1 år)
-25.60%
Land
TW
Handel Medeon Biodesign, Inc. (6499)

Kategori

P/B-forhold for Medeon Biodesign, Inc. (6499)
P/B-forhold per 2026 TTM: 0
Ifølge Medeon Biodesign, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Medeon Biodesign, Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
43.2973 -
US
3.0864 -
KR
- -
JP
5.6231 -
JP
- -
CN